4.5 Review

The future of diagnosis in clinical neurosciences: Comparing multiple sclerosis and schizophrenia

Related references

Note: Only part of the references are listed.
Article Neurosciences

Diagnosis of schizophrenia with functional connectome data: a graph-based convolutional neural network approach

Kang-Han Oh et al.

Summary: The study developed a new neural network model called BrainNet-GA CNN for classifying patients with schizophrenia spectrum disorders (SSDs) and healthy controls (HCs). The model incorporated deep learning techniques and global covariance pooling, and demonstrated high accuracy and important clinical information.

BMC NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

MiR-574-5P, miR-1827, and miR-4429 as Potential Biomarkers for Schizophrenia

Omran Davarinejad et al.

Summary: The study utilized various analytical methods to identify molecular biomarkers for schizophrenia, confirming three miRNAs as potential diagnostic biomarkers, providing new insights for disease diagnosis.

JOURNAL OF MOLECULAR NEUROSCIENCE (2022)

Article Medicine, General & Internal

Schizophrenia

Sameer Jauhar et al.

LANCET (2022)

Article Psychiatry

The Kraepelian concept of schizophrenia: Dying but not yet dead

Robin M. Murray et al.

SCHIZOPHRENIA RESEARCH (2022)

Article Neurosciences

Neural Correlates of the Risk for Schizophrenia and Bipolar Disorder: A Meta-analysis of Structural and Functional Neuroimaging Studies

Giulia Cattarinussi et al.

Summary: Relatives of individuals with schizophrenia and bipolar disorder show alterations in brain structure and function, potentially reflecting shared genetic mechanisms underlying both disorders.

BIOLOGICAL PSYCHIATRY (2022)

Review Medical Laboratory Technology

Oligoclonal bands: clinical utility and interpretation cues

Sara Carta et al.

Summary: Oligoclonal immunoglobulin G (IgG) bands (OCBs) are a diagnostic tool for detecting central humoral response. OCBs can be used for diagnosis and prognosis assessment of multiple sclerosis and other diseases, but there are technical issues in interpreting the results.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2022)

Review Psychiatry

Psychotic symptoms prior or concomitant to diagnosis of multiple sclerosis: a systematic review of case reports and case series

Michel Sabe et al.

Summary: The study found that psychotic symptoms preceding or concomitant to multiple sclerosis (MS) diagnosis are common, with delusions, auditory hallucinations, and visual hallucinations being the most reported symptoms. Immunosuppressive therapy was found to be significantly more effective than antipsychotics. Cases with predominant temporal lesions were more likely to present visual hallucinations.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2022)

Article Clinical Neurology

European Academy of Neurology 2019-2022

Claudio L. A. Bassetti

Summary: Founded in 2014, the European Academy of Neurology (EAN) aims to reduce the burden of neurological disorders. Over the past three years, the EAN has focused on education, science, membership, and advocacy. The outbreak of COVID-19 in 2020 brought significant changes to the EAN, including the implementation of new digital technologies. The virtual congress in 2020 saw record levels of attendance, and various initiatives and programs were launched to improve neurological care and advance scientific research.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Review Biochemistry & Molecular Biology

Systematic Review and Meta-Analysis of Mass Spectrometry Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Schizophrenia

Joao E. Rodrigues et al.

Summary: Mass spectrometry (MS)-based proteomics can effectively identify biomarkers and relevant biological pathways in schizophrenia (SCZ) patients, providing potential targets for prediction and diagnosis improvement. This study identified 217 differentially expressed proteins in SCZ patients through meta-analysis of 19 articles using MS proteomics approaches. Enriched biological pathways included lipid metabolism, complement and coagulation cascades, and immune response. The upregulation of FCN3 and downregulation of APO1, APOA2, APOC1, and APOC3 were suggested as potential biomarkers for SCZ. However, heterogeneity in the findings and confounding factors should be taken into account for future studies to enhance the understanding of differentially expressed proteins.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Editorial Material Clinical Neurology

Multiple sclerosis: two decades of progress

Bruce A. C. Cree et al.

LANCET NEUROLOGY (2022)

Article Multidisciplinary Sciences

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

Vassily Trubetskoy et al.

Summary: In this study, a two-stage genome-wide association study was conducted to identify common variants associated with schizophrenia. The results revealed 287 distinct genomic loci and 120 genes likely to be involved in the development of schizophrenia. This research provides valuable insights into the pathophysiology of schizophrenia and offers a resource for further mechanistic studies.

NATURE (2022)

Review Clinical Neurology

Therapeutic Advances in Multiple Sclerosis

Jennifer H. Yang et al.

Summary: Multiple sclerosis is an autoimmune disease affecting the central nervous system, causing significant disability and healthcare burden. Treatment options have evolved over the past three decades, with the development of new disease modifying therapies targeting various mechanisms.

FRONTIERS IN NEUROLOGY (2022)

Review Psychiatry

Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics

Christoph U. Correll et al.

Summary: Clinical practice guidelines translate evidence into recommendations for improving patient care and outcomes. This review summarizes the recommendations for acute and maintenance management of schizophrenia with antipsychotics based on a systematic literature review of English-language guidelines. The guidelines recommend antipsychotic monotherapy for first-episode schizophrenia, but no consensus on the preferred antipsychotic. There is also variation in recommendations for the maximum duration of maintenance therapy and the use of long-acting injectable antipsychotics. Clozapine is recommended for treatment-resistant schizophrenia.

SCHIZOPHRENIA (2022)

Review Psychiatry

The Current State and Validity of Digital Assessment Tools for Psychiatry: Systematic Review

Nayra A. Martin-Key et al.

Summary: This review examines the current state and validity of question-and-answer-based digital tools for diagnosing and screening psychiatric conditions in adults. The findings reveal varying levels of screening or diagnostic accuracy for these tools and a high risk of bias in most of the included studies.

JMIR MENTAL HEALTH (2022)

Article Immunology

Genome-wide analysis of schizophrenia and multiple sclerosis identifies shared genomic loci with mixed direction of effects

Mohammad Ahangari et al.

Summary: Despite a negligible genetic correlation, there is polygenic overlap between schizophrenia and multiple sclerosis, with substantial genetic enrichment in each disorder conditional on associations with the other. Leveraging this cross-disorder enrichment, 36 loci jointly associated with schizophrenia and multiple sclerosis were identified at conjunctional FDR < 0.05 with mixed direction of effects. By conducting functional analysis, candidate genes and biological processes related to immune response and B-cell receptor signaling pathways were implicated in the shared genetic architecture of these two disorders.

BRAIN BEHAVIOR AND IMMUNITY (2022)

Review Psychiatry

The prognosis of schizophrenia: A systematic review and meta-analysis with meta-regression of 20-year follow-up studies

Ida-Marie Molstrom et al.

Summary: The study findings suggest that schizophrenia does not inevitably have a deteriorating course. Recovery is possible. Despite over 100 years of research and efforts to improve treatment, schizophrenia remains a severe and complex mental disorder with limited changes in prognosis.

SCHIZOPHRENIA RESEARCH (2022)

Article Clinical Neurology

The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades

Lucia Romero-Pinel et al.

Summary: The age at onset of relapsing-remitting multiple sclerosis (RRMS) has increased over the past decades, according to this study.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)

Article Psychiatry

Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration

Dan J. Stein et al.

Summary: Psychiatry has been characterized by different models and approaches to mental disorder. The focus of debate in recent decades has been on psychiatric nosology and the need for new paradigms. Despite the development of evidence-based treatments, there is still a treatment and research-practice gap in mental health. Novel perspectives such as clinical neuroscience and personalized pharmacotherapy, statistical approaches, community mental health care, digital therapies, and global mental health approaches have the potential to impact psychiatric practice and research.

WORLD PSYCHIATRY (2022)

Article Multidisciplinary Sciences

Derivation and utility of schizophrenia polygenic risk associated multimodal MRI frontotemporal network

Shile Qi et al.

Summary: Schizophrenia is a highly heritable psychiatric disorder characterized by widespread brain abnormalities. This study identifies a multimodal frontotemporal network associated with schizophrenia polygenic risk, serving as a specific brain biomarker for schizophrenia.

NATURE COMMUNICATIONS (2022)

Article Health Care Sciences & Services

Polygenic Risk Score and Risk Factors for Gestational Diabetes

Marija Majda Perisic et al.

Summary: A polygenic risk score for GDM was developed to investigate its genetic architecture and its relation to genetically constructed risk factors and biomarkers. The polygenic risk score can be used as an early screening tool to identify women at higher risk of GDM for comprehensive monitoring and preventative programs.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Review Immunology

The immunology of multiple sclerosis

Kathrine E. Attfield et al.

Summary: Our incomplete understanding of the causes and pathways of multiple sclerosis limits effective treatment. Recent studies explore the role of immune cells and the influence of environmental factors, highlighting the importance of understanding the mechanisms behind causal cell types.

NATURE REVIEWS IMMUNOLOGY (2022)

Review Psychology, Clinical

Linking RDoC and HiTOP: A new interface for advancing psychiatric nosology and neuroscience

Giorgia Michelini et al.

Summary: The Research Domain Criteria (RDoC) and the Hierarchical Taxonomy of Psychopathology (HiTOP) are two major dimensional frameworks proposing alternative approaches to accelerate progress in studying and treating psychopathology. Their complementary strengths can be leveraged to provide more informative clinical targets and ultimately advance clinical neuroscience and psychiatric nosology.

CLINICAL PSYCHOLOGY REVIEW (2021)

Review Neurosciences

Biotyping in psychosis: using multiple computational approaches with one data set

Carol A. Tamminga et al.

Summary: The review focuses on the importance of utilizing phenotype data and big data computations to understand psychosis and contribute to disease cognition and treatment. The goal is to establish guiding principles and reveal common areas to enhance target identification and treatment development.

NEUROPSYCHOPHARMACOLOGY (2021)

Article Multidisciplinary Sciences

Deep learning encodes robust discriminative neuroimaging representations to outperform standard machine learning

Anees Abrol et al.

Summary: Recent findings suggest that when trained following prevalent deep learning practices, deep learning methods significantly outperform standard machine learning methods in brain imaging data analysis by encoding robust discriminative brain representations.

NATURE COMMUNICATIONS (2021)

Article Computer Science, Artificial Intelligence

Advanced EEG-based learning approaches to predict schizophrenia: Promises and pitfalls

Carla Barros et al.

Summary: The complexity and heterogeneity of schizophrenia symptoms present challenges for objective diagnosis, but early detection can lead to improved treatment outcomes. Recent research has focused on neurobiological mechanisms and biomarkers for schizophrenia, as well as utilizing machine learning techniques for classification. Further clinical validation and research are necessary for the development of effective EEG-based models and interventions.

ARTIFICIAL INTELLIGENCE IN MEDICINE (2021)

Article Health Care Sciences & Services

What Can We Learn from Sex Differences in MS?

Patricia K. Coyle

Summary: Multiple sclerosis is a major central nervous system disease that predominantly affects young adults, with females being more susceptible than males. Research has shown that sex-based differences influence various aspects of multiple sclerosis, leading to new insights in understanding, management, and treatment of the disease.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Review Psychiatry

EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review

Andrea Perrottelli et al.

Summary: Electrophysiological abnormalities have been found in individuals with schizophrenia, particularly in the prodromal and early phases of the disorder. These abnormalities include increased delta and gamma power, sensory gating impairment, and reductions in certain brain responses. Changes in these electrophysiological measures are associated with the transition to psychosis and disease progression. However, more research is needed to draw solid conclusions due to the heterogeneity in inclusion criteria and methods used in studies.

FRONTIERS IN PSYCHIATRY (2021)

Article Psychiatry

The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality

John Torous et al.

Summary: This paper provides a comprehensive update on the field of digital psychiatry, outlining recent technological advances, applications, and challenges. New technologies such as smartphones, social media, artificial intelligence, and virtual reality are increasingly influencing mental health research and care. Further efforts towards implementation are needed to fully realize the potential of digital health technologies in improving mental health treatment and research.

WORLD PSYCHIATRY (2021)

Review Psychiatry

Proportion and predictors of remission and recovery in first-episode psychosis: Systematic review and meta-analysis

Ana Catalan et al.

Summary: The study found that approximately half of patients experience symptomatic remission around four years after FEP, while about a third show recovery after 5.5 years. No significant effects of sociodemographic or clinical predictors were found.

EUROPEAN PSYCHIATRY (2021)

Article Neurosciences

Neuroimaging in Schizophrenia

Matcheri S. Keshavan et al.

NEUROIMAGING CLINICS OF NORTH AMERICA (2020)

Article Clinical Neurology

Neuroimaging of Multiple Sclerosis Mimics

Yathish Haralur et al.

NEUROLOGIC CLINICS (2020)

Review Psychiatry

Schizophrenia in ICD-11: Comparison of ICD-10 and DSM-5

Ruben Valle

REVISTA DE PSIQUIATRIA Y SALUD MENTAL (2020)

Article Biochemistry & Molecular Biology

A neuroimaging biomarker for striatal dysfunction in schizophrenia

Ang Li et al.

NATURE MEDICINE (2020)

Review Psychiatry

Systematic Review of Digital Phenotyping and Machine Learning in Psychosis Spectrum Illnesses

James Benoit et al.

HARVARD REVIEW OF PSYCHIATRY (2020)

Article Public, Environmental & Occupational Health

The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017

Günther Deuschl et al.

Lancet Public Health (2020)

Article Psychiatry

Blood tests to diagnose schizophrenia: self-imposed limits in psychiatry

Carsten Korth et al.

LANCET PSYCHIATRY (2020)

Article Neurosciences

Changes from ICD-10 to ICD-11 and future directions in psychiatric classification

Wolfgang Gaebel et al.

DIALOGUES IN CLINICAL NEUROSCIENCE (2020)

Article Neurosciences

Fractures in the framework: limitations of classification systems in psychiatry

Munira Kapadia et al.

DIALOGUES IN CLINICAL NEUROSCIENCE (2020)

Review Psychiatry

Diagnostic stability of schizophrenia: A systematic review

Nora Palomar-Ciria et al.

PSYCHIATRY RESEARCH (2019)

Editorial Material Psychiatry

Toward High Reproducibility and Accountable Heterogeneity in Schizophrenia Research

Peter Kochunov et al.

JAMA PSYCHIATRY (2019)

Article Multidisciplinary Sciences

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

Nikolas A. Patsopoulos et al.

SCIENCE (2019)

Review Immunology

The immunogenetics of neurological disease

Maneesh K. Misra et al.

IMMUNOLOGY (2018)

Article Clinical Neurology

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria

Georgina Arrambide et al.

BRAIN (2018)

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Article Neurosciences

The genetic architecture of schizophrenia, bipolar disorder, obsessive-compulsive disorder and autism spectrum disorder

Kevin S. O'Connell et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2018)

Article Multidisciplinary Sciences

Combining multi-modality data for searching biomarkers in schizophrenia

Shuixia Guo et al.

PLOS ONE (2018)

Review Psychiatry

What causes psychosis? An umbrella review of risk and protective factors

Joaquim Radua et al.

WORLD PSYCHIATRY (2018)

Article Medicine, Research & Experimental

Genetics of Multiple Sclerosis: An Overview and New Directions

Nikolaos A. Patsopoulos

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)

Article Medicine, Research & Experimental

Clinical Course of Multiple Sclerosis

Sylvia Klineova et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)

Review Public, Environmental & Occupational Health

A systematic review of the indirect costs of schizophrenia in Europe

A. Fasseeh et al.

EUROPEAN JOURNAL OF PUBLIC HEALTH (2018)

Article Health Care Sciences & Services

New tests, new tools: mobile and connected technologies in advancing psychiatric diagnosis

Laura Weiss Roberts et al.

NPJ DIGITAL MEDICINE (2018)

Article Health Care Sciences & Services

What to expect from reliability and validity claims? A pragmatic conception of psychiatric nosology

Sander Lefere et al.

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2017)

Review Biochemistry & Molecular Biology

Multiple Sclerosis and Schizophrenia

Borros M. Arneth

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Medicine, General & Internal

Diagnosis of multiple sclerosis: progress and challenges

Wallace J. Brownlee et al.

LANCET (2017)

Review Clinical Neurology

The varieties of psychosis in multiple sclerosis: A systematic review of cases

Carlos R. Camara-Lemarroy et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)

Article Psychology, Clinical

The Hierarchical Taxonomy of Psychopathology (HiTOP): A Dimensional Alternative to Traditional Nosologies

Roman Kotov et al.

JOURNAL OF ABNORMAL PSYCHOLOGY (2017)

Review Psychology, Clinical

Clashing Diagnostic Approaches: DSM-ICD Versus RDoC

Scott O. Lilienfeld et al.

ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 12 (2016)

Article Psychiatry

Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis

Arianna Marconi et al.

SCHIZOPHRENIA BULLETIN (2016)

Article Psychiatry

The dysconnection hypothesis (2016)

Karl Friston et al.

SCHIZOPHRENIA RESEARCH (2016)

Article Psychiatry

Psychiatric classifications: validity and utility

Assen Jablensky

WORLD PSYCHIATRY (2016)

Review Clinical Neurology

Glutamate and dopamine in schizophrenia: An update for the 21st century

Oliver Howes et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2015)

Article Clinical Neurology

Impact of multiple sclerosis relapse: The NARCOMS participant perspective

Molly Nickerson et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)

Article Psychology, Clinical

The Reliability of Clinical Diagnoses: State of the Art

Helena Chmura Kraemer

ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 10 (2014)

Article Clinical Neurology

Multiple sclerosis and psychiatric disorders: Comorbidity and sibling risk in a nationwide Swedish cohort

Viktoria Johansson et al.

MULTIPLE SCLEROSIS JOURNAL (2014)

Article Psychiatry

Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder

Thomas G. Schulze et al.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2014)

Editorial Material Clinical Neurology

INTERNATIONAL CLASSIFICATION OF DISEASES (ICD-11) AND NEUROLOGIC DISORDERS: THE FUTURE

Raad Shakir et al.

NEUROLOGY (2013)

Review Psychiatry

Definition and description of schizophrenia in the DSM-5

Rajiv Tandon et al.

SCHIZOPHRENIA RESEARCH (2013)

Editorial Material Psychiatry

Status of Psychotic Disorders in ICD-11

Wolfgang Gaebel

SCHIZOPHRENIA BULLETIN (2012)

Article Clinical Neurology

Cerebrospinal fluid diagnostics in first-episode schizophrenia

Laura Kranaster et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2011)

Article Psychiatry

Neurological Soft Signs in Schizophrenia: A Meta-analysis

Raymond C. K. Chan et al.

SCHIZOPHRENIA BULLETIN (2010)

Article Psychiatry

Sex differences in schizophrenia

Kathryn M. Abel et al.

INTERNATIONAL REVIEW OF PSYCHIATRY (2010)

Review Genetics & Heredity

Genetic overlap between autism, schizophrenia and bipolar disorder

Liam S. Carroll et al.

GENOME MEDICINE (2009)

Article Clinical Neurology

Concordance and heritability of multiple sclerosis in Finland: study on a nationwide series of twins

H. Kuusisto et al.

EUROPEAN JOURNAL OF NEUROLOGY (2008)

Review Neurosciences

Genes, dopamine and cortical signal-to-noise ratio in schizophrenia

G Winterer et al.

TRENDS IN NEUROSCIENCES (2004)

Article Multidisciplinary Sciences

Twin concordance and sibling recurrence rates in multiple sclerosis

CJ Willer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Psychiatry

Schizophrenia as a complex trait - Evidence from a meta-analysis of twin studies

PF Sullivan et al.

ARCHIVES OF GENERAL PSYCHIATRY (2003)